US equities
|
NVDA
$153.77
▼-1.09%
MU
$708.83
▼-0.50%
AMD
$511.46
▲+1.60%
SPCX
$145.82
▲+2.91%
SNDK
$775.15
▼-2.77%
AAPL
$352.98
▲+0.30%
TSLA
$381.44
▲+0.35%
AMZN
$264.48
▲+2.56%
NVDA
$153.77
▼-1.09%
MU
$708.83
▼-0.50%
AMD
$511.46
▲+1.60%
SPCX
$145.82
▲+2.91%
SNDK
$775.15
▼-2.77%
AAPL
$352.98
▲+0.30%
TSLA
$381.44
▲+0.35%
AMZN
$264.48
▲+2.56%
FinancialContent
Sign in
Markets
Overview
News
World markets
Treasuries
Currencies
Commodities
Economy
Stocks
Overview
Most active
Gainers
Losers
Largest companies
52-week gainers
52-week losers
ETFs
Overview
Popular funds
Most active
Gainers
Losers
News
Research
Search
Sectors
Tools
My watchlist
My portfolio
Recent quotes
Latest News about TSX:CRDL
Recent news which mentions TSX:CRDL
Cardiol Therapeutics releases positive study results of subcutaneously administered cannabidiol
October 11, 2023
Tags
TSX:CRDL
NASDAQ:CRDL
From
News Direct
Cardiol Therapeutics says first patient enrolled in Phase 2 study of CardiolRx for Pericarditis
January 17, 2023
Tags
NASDAQ:CRDL
TSX:CRDL
From
News Direct
Cardiol Therapeutics begins Phase II study of CardiolRx for treatment of recurrent pericarditis
December 16, 2022
Tags
NASDAQ:CRDL
TSX:CRDL
From
News Direct